Ernexa Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $12.9M
Liabilities Breakdown FY2020
Total Liabilities: $5.2M
Asset Breakdown
Total Assets: $12.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $777.0K | 6.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $594.0K | 4.6% |
| Goodwill | $2.0M | 15.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.5M | 73.5% |
Liabilities Breakdown
Total Liabilities: $5.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 24.3% |
| Long-Term Debt | $532.0K | 10.1% |
| Other Liabilities | $3.4M | 65.6% |